Elder Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AngioDynamics, Inc.
Peripheral vascular disease-focused company reports net income up 70%
October 26th, 2005
AngioDynamics, Inc., (ANGO) announced financial results for the 13 weeks ended August 27, 2005 with a 25% increase in net sales to $16.4 million, up from $13.1 million in the first quarter of fiscal 2005. This increase reflects strong growth from the company's newest products, along with continued market share gains across the diversified product portfolio. Most of the revenue gains were due to increased unit sales, with a modest price increase contributing 1.6% to the total revenue growth. Angiographic product sales increased 10% over the first quarter of fiscal 2005, with sales of $4.6 million for the first quarter of fiscal 2006. Sales of the...
Source: Elder Law Weekly (2005-10-26)
|
